- Home
- APGE vs ATAT Comparison
APGE vs ATAT Comparison
Compare APGE & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | ATAT |
|---|---|---|
| Founded | 2022 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.1B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APGE | ATAT |
|---|---|---|
| Price | $90.54 | $39.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $109.67 | $49.00 |
| AVG Volume (30 Days) | 881.1K | ★ 1.0M |
| Earning Date | 05-11-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.48 |
| Revenue Next Year | N/A | $18.11 |
| P/E Ratio | ★ N/A | $26.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.34 | $23.19 |
| 52 Week High | $95.32 | $43.17 |
Technical Indicators
Market Signals| Indicator | APGE | ATAT |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 61.93 |
| Support Level | $73.06 | $34.31 |
| Resistance Level | N/A | $40.79 |
| Average True Range (ATR) | 3.27 | 1.19 |
| MACD | 0.23 | 0.34 |
| Stochastic Oscillator | 64.72 | 85.92 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.